These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23185346)
1. Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. Kalyoussef S; Nieves E; Dinerman E; Carpenter C; Shankar V; Oh J; Burd B; Angeletti RH; Buckheit KW; Fredricks DN; Madan RP; Keller MJ; Herold BC PLoS One; 2012; 7(11):e49506. PubMed ID: 23185346 [TBL] [Abstract][Full Text] [Related]
2. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008 [TBL] [Abstract][Full Text] [Related]
3. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive. Keller MJ; Carpenter CA; Lo Y; Einstein MH; Liu C; Fredricks DN; Herold BC PLoS One; 2012; 7(10):e46901. PubMed ID: 23056520 [TBL] [Abstract][Full Text] [Related]
4. Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. Ghartey JP; Smith BC; Chen Z; Buckley N; Lo Y; Ratner AJ; Herold BC; Burk RD PLoS One; 2014; 9(5):e96659. PubMed ID: 24805362 [TBL] [Abstract][Full Text] [Related]
5. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection. Murphy K; Keller MJ; Anastos K; Sinclair S; Devlin JC; Shi Q; Hoover DR; Starkman B; McGillick J; Mullis C; Minkoff H; Dominguez-Bello MG; Herold BC PLoS One; 2019; 14(4):e0216049. PubMed ID: 31026271 [TBL] [Abstract][Full Text] [Related]
6. Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents. Madan RP; Carpenter C; Fiedler T; Kalyoussef S; McAndrew TC; Viswanathan S; Kim M; Keller MJ; Fredricks DN; Herold BC PLoS One; 2012; 7(7):e40415. PubMed ID: 22808157 [TBL] [Abstract][Full Text] [Related]
7. Bacterial colonization and beta defensins in the female genital tract in HIV infection. Jiang W; Ghosh SK; Flyckt R; Kalinowska M; Starks D; Jurevic R; Weinberg A; Lederman MM; Rodriguez B Curr HIV Res; 2012 Sep; 10(6):504-12. PubMed ID: 22716110 [TBL] [Abstract][Full Text] [Related]
8. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis. Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809 [TBL] [Abstract][Full Text] [Related]
9. Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus. Agarwal N; Buckley N; Nakra N; Gialanella P; Yuan W; Ghartey JP Am J Reprod Immunol; 2015 Dec; 74(6):499-507. PubMed ID: 26395128 [TBL] [Abstract][Full Text] [Related]
10. Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of Atassi F; Pho Viet Ahn DL; Lievin-Le Moal V Front Microbiol; 2019; 10():2900. PubMed ID: 31921075 [TBL] [Abstract][Full Text] [Related]
11. Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition. Pellett Madan R; Masson L; Tugetman J; Werner L; Grobler A; Mlisana K; Lo Y; Che D; Arnold KB; Abdool Karim SS; Passmore JA; Herold BC AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1153-9. PubMed ID: 26061218 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women. Keller MJ; McGinn AP; Lo Y; Huber A; Espinoza L; Minkoff H; Colie C; Nowicki MJ; D'Souza G; Anastos K Am J Reprod Immunol; 2016 Jun; 75(6):631-42. PubMed ID: 27145926 [TBL] [Abstract][Full Text] [Related]
13. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention. Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460 [TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal Microbiome Composition Is Associated with Metabolic Profiles in Healthy Pregnancy. Oliver A; LaMere B; Weihe C; Wandro S; Lindsay KL; Wadhwa PD; Mills DA; Pride DT; Fiehn O; Northen T; de Raad M; Li H; Martiny JBH; Lynch S; Whiteson K mBio; 2020 Aug; 11(4):. PubMed ID: 32843557 [TBL] [Abstract][Full Text] [Related]
15. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461 [TBL] [Abstract][Full Text] [Related]
16. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397 [TBL] [Abstract][Full Text] [Related]
17. Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis. Yan DH; Lü Z; Su JR Chin Med J (Engl); 2009 Nov; 122(22):2748-51. PubMed ID: 19951608 [TBL] [Abstract][Full Text] [Related]
18. Parallel detection of lactobacillus and bacterial vaginosis-associated bacterial DNA in the chorioamnion and vagina of pregnant women at term. Lannon SMR; Adams Waldorf KM; Fiedler T; Kapur RP; Agnew K; Rajagopal L; Gravett MG; Fredricks DN J Matern Fetal Neonatal Med; 2019 Aug; 32(16):2702-2710. PubMed ID: 29478370 [TBL] [Abstract][Full Text] [Related]
19. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. Doerflinger SY; Throop AL; Herbst-Kralovetz MM J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560 [TBL] [Abstract][Full Text] [Related]
20. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women. Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]